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Physical interaction
Membrane hyperpolarizationHuman left internal mammary arteries (LIMAs) are commonly used as donor grafts for coronary bypass surgery.
Previous reports suggested that 11,12-epoxyeicosatrienoic acid (11,12-EET) is an important endothelial-derived
hyperpolarizing factor (EDHF) in human LIMAs and that EETs act through large conductance Ca2+-activated K+
channels (KCa1.1) to induce smooth muscle cell hyperpolarization and relaxation in these tissues. In this study,
we aimed to explore the role of vanilloid transient receptor potential channel 4 (TRPV4) and canonical transient
receptor potential channel 1 (TRPC1) channels in the EET-induced smooth muscle hyperpolarization and vascu-
lar relaxation in human LIMAs. Co-immunoprecipitation studies demonstrated that TRPV4, TRPC1, and KCa1.1
physically interactedwith each other to forma complex. Sharpmicroelectrode and vascular tension studies dem-
onstrated that 11,12-EET (300 nmol/L) and 4α-phorbol 12,13-didecanoate (5 μmol/L) were able to induce
smooth muscle membrane hyperpolarization and vascular relaxation in isolated human LIMA segments. The
hyperpolarizing and relaxant effects were markedly reduced by treatments that could suppress the expres-
sion/activity of TRPV4, TRPC1, or KCa1.1. With the use of human embryonic kidney 293 cells that over-
expressed with TRPV4, TRPC1 and KCa1.1, we found that TRPC1 is the linker through which TRPV4 and
KCa1.1(α) can interact. The present study revealed that 11,12-EET targets the TRPV4–TRPC1–KCa1.1 complex to
induce smooth muscle cell hyperpolarization and vascular relaxation in human LIMAs. This ﬁnding provides
novel mechanistic insights for the EET action in human LIMAs.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
EETs are cytochrome P450 epoxygenase metabolites of arachidonic
acid that are released from vascular endothelial cells in response to bra-
dykinin, pulsatile stretch and shear stress [1,2]. In vasculature, P450 2Cteries;EETs,epoxyeicosatrienoic
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ao2068@cuhk.edu.hk (X. Yao).and 2J epoxygenases are the most important families to modulate
vascular tone. To date, the molecular targets of EETs are still fully unre-
solved. One potential target for 5,6-EET and 11,12-EET is vanilloid tran-
sient receptor potential channel 4 (TRPV4) [1]. TRPV4 contains a
putative arachidonate recognition site in its N-terminal cytoplasmic
domain, towhich EETs could potentially bind [3]. Functionally, in rat ce-
rebral arteries EETs activate TRPV4 in vascular smooth muscle cells
(VSMCs) to induce Ca2+ inﬂux, which stimulates ryanodine receptors
(RyR), causing subsequent activation of KCa1.1. Activity of KCa1.1 leads
to smoothmuscle cell hyperpolarization and consequent vascular relax-
ation [4]. In addition, EETs may also activate TRPV4 channels in endo-
thelial cells, resulting in endothelial cell hyperpolarization via KCa3.1
and KCa2.3 [5,6]. Besides their action on TRPV4, EETs are suggested to
stimulate vesicular translocation of canonical transient receptor poten-
tial channel 6 (TRPC6) towards the plasmamembrane [7] and to inhibit
volume-activated Cl− channels via a cGMP-dependent pathway [8].
TRPC1 is another Ca2+-permeable channel that has been reported to
play an important functional role in vascular tone control [9–13].
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has pro-contractile or anti-contractile function in VSMCs [9–13]. On
the one hand, hypoxic treatment was reported to enhance TRPC1
protein expression with a parallel increase in vascular contractility in
pulmonary arteries [9–11]. Furthermore, inhibiting TRPC1 activity by
an anti-TRPC1 antibody T1E3 attenuated the endothelin-1-evoked
contraction in rat basilar artery [9]. These studies suggested a pro-
contractile function of TRPC1 in VSMCs. On the other hand, several
recent reports suggested that TRPC1may have an anti-contractile func-
tion. We previously reported that TRPC1 and KCa1.1 are physically
coupled in VSMCs and that Ca2+ entry through TRPC1 activates KCa1.1
to hyperpolarize VSMCs, resulting in smooth muscle relaxation in rat
aortic and mesenteric arteries [12]. This hypothesis of anti-contractile
function of TRPC1 was recently conﬁrmed by Marrelli's group with the
use of TRPC1 knockout mice [13]. The reason for the discrepancy in
the results regarding the pro- or anti-contractile function of TRPC1 is
unclear, but it could be related to the difference in artery bed types
and/or physiological conditions.
In the present study, we utilized human left internal mammary
arteries (LIMAs) as the model to investigate the role of TRPV4 and
TRPC1 in EET-induced vascular relaxation. Human LIMAs are often
used as donor vessels in coronary bypass surgery due to their relative
resistance to atherosclerosis and superior endothelial function [14,15].
Thus it is of clinical importance to understand the underlying mecha-
nism of vascular tone control in these arteries. Previous studies demon-
strated that endothelial cells of LIMAs not only release large amounts of
nitric oxide and prostacyclin [14,16], but also produce endothelium-
derived hyperpolarizing factors (EDHFs). The predominate EDHF in
human LIMAs is 11,12-EET [17]. 11,12-EET activates the KCa1.1 current
to induce smooth muscle cell hyperpolarization, consequently causing
vascular relaxation of human LIMAs [17]. However, up to the present
it is still unknown whether TRPV4 and/or TRPC1 play any role in EET-
induced vascular relaxation in human LIMAs. Here, we employed elec-
trophysiological and molecular biological techniques to explore the
involvement of TRPV4 and TRPC1 in EET-induced smooth muscle hy-
perpolarization and relaxation in human LIMAs.
2. Materials and methods
2.1. Materials
HEK293 was from ATCC, USA. The primary rabbit antibodies against
KCa1.1(α) (APC-021), TRPC1 (ACC-010), and TRPV4 (ACC-034) were
from Alomone Labs. T1E3 was raised by us from rabbits. Protein
A-agarose and protease inhibitor cocktail tablets were from Roche.
Lipofectamine 2000, fetal bovine serum (FBS), Dulbecco's modiﬁed
Eagle's medium (DMEM), medium 231, smoothmuscle growth supple-
ment, phosphate buffered saline (PBS), and dithiothreitol were from
Invitrogen. Fluo-4/AM and pluronic F127 were from Molecular Probes
Inc. 4α-PDD was from Calbiochem. HC-067047 and GSK1016790A
were from Sigma. (±)11,12-EET was from Cayman Chemical. Papain
was from Fluka. Nonidet P-40, iberiotoxin, trypsin, albumin bovine
serum (BSA), collagenase and poly-L-lysine were from Sigma.
2.2. Cell and tissue preparation and culture
Human LIMA segments were from discarded tissues at the time of
coronary artery bypass grafting with the written consent of family
members and the approval of the Clinical Research Ethics Committee,
Chinese University of Hong Kong. The investigation conforms with the
principles outlined in the Declaration of Helsinki for the use of human
tissue or subjects.
To isolate the primary VSMCs, LIMAs were dissected and the lumen
of the artery was cut open. Endothelial layer wasmechanically denuded
by rubbing the lumen with cotton wool. Smooth muscle layers were
peeled off from adventitial layers with forceps, and were digested in aCa2+-free PBS containing 0.2% collagenase type 1A, 0.9% papain, 0.5%
BSA and 10 μmol/L dithiothreitol at 37 °C for 1 h. The dispersed VSMCs
were washed with PBS and then cultured for 3–4 days in medium 231
with smooth muscle growth supplement, 100 μg/mL penicillin, and
100 U/mL streptomycin. These cells were used for co-immunopre-
cipitation experiments without further passage. HEK293 cells were cul-
tured in DMEM supplemented with 10% FBS, 100 μg/mL penicillin and
100 U/mL streptomycin.
2.3. Cloning and transfection
Human KCa1.1(α) cDNA (NM_002247) is a gift from Dr. Desir GV,
Yale University. Human TRPC1 cDNA (NM_003304) was obtained by
RT-PCR from human coronary endothelial cells CC2585 (BioWhittaker).
Mouse TRPV4 gene (NM_022017) was a gift from Dr. Nilius B, Belgium.
TRPC1mut-pore was a gift from Dr. Ambudkar I, NIH, USA. TRPC1 and
KCa1.1(α) genes were cloned into pcDNA6 vector, and TRPV4 gene
was cloned into pcAGGS vector for expression. The nucleotide se-
quences of all constructs were veriﬁed with DNA sequencing. TRPV4-
siRNAs and scrambled controls were from Ambion, Texas, USA. The
sequences for human TRPV4-siRNA were GUCUUCAACCGGCCUA
UCCuu (sense sequence) and GGAUAGGCCGGUUGAAGACuu (antisense
sequence) as described by others [18].
Transfection condition was as described elsewhere [19]. Brieﬂy,
HEK293 cells were transfected with various constructs using Lipofecta-
mine 2000. About 6 × 104 HEK293 cells were grown in each well of the
6-well plates. Transfectionwas donewith 4 μg plasmid and 6 μL Lipofec-
tamine 2000 in 200 μL Opti-MEM reduced serum medium in 6-well
plates. VSMCs were transfected by electroporation using Nucleofector
II following the procedure in the manufacturer's instruction manual. If
needed, LIMA segments were transfected with TRPV4 (human)-siRNA
using Lipofectamine RNAiMAX following the protocol used elsewhere
[6,20]. Brieﬂy, LIMA was cut into ~2 mm segments and cultured in a
24-well plate. Transfection was performed with 50 nmol/L siRNA and
1.5 μL Lipofectamine RNAiMAX in 500 μL Opti-MEM reduced serumme-
dium. After 6-hour incubation, the transfection medium was replaced
by DMEM. Tissues were ready for functional studies after 24–48 h
post-transfection. The culture medium was changed every day. About
80% of HEK293 cells were successfully transfected by respective proto-
cols as indicated by control transfection using aGFP-expressing pCAGGS
vector. All genes were transiently transfected into targeted cells. Func-
tional studies were performed 2–3 days post-transfection.
2.4. Preparation of T1E3 and preimmune IgG
T1E3 antibody was raised in rabbits using the strategy developed by
Xu et al. [12,21]. Brieﬂy, a peptide corresponding to the E3 region near
the ion permeation pore, between transmembrane regions S5 and S6,
of TRPC1 (CVGIFCEQQSNDTFHSFIGT) was synthesized and conjugated
to keyhole limpet hemocyanin (KLH) at Alpha Diagnostic International
(USA). The coupled T1E3 peptide was injected to the back of a rabbit
(day 0), followed by two boost doses at day 21 and day 42, respectively.
Antiserum was collected four weeks after the second boost. Immuno-
globulin Gwas puriﬁed from the T1E3 antiserum using a HiTrap Protein
G column (GEHealthcare). For control, pre-immune serumwas puriﬁed
with a HiTrap Protein G column to obtain the immunoglobulin G, which
was then used in the experiments.
2.5. Immunoprecipitation and immunoblots
Immunoprecipitation and immunoblots were described previously
[12]. Proteins were extracted with a detergent-containing extraction
buffer, which contained 1% (vol/vol) Nonidet P-40, 150 mmol/L NaCl,
and 20mmol/L Tris–HCl, pH 8.0, with the addition of protease inhibitor
cocktail tablets. 800 μg of extracted proteins was then incubated with
7 μg of anti-TRPC1 (ACC-010; Alomone Laboratory), anti-TRPV4 (ACC-
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ratory) antibody on a rocking platform overnight at 4 °C. Protein A
agarose was then added, followed by further incubation at 4 °C for 3 h.
The immunoprecipitates were washed with saline 3 times and
resolved on 8% SDS-PAGE gel. The proteins were then transferred onto
a polyvinylidene diﬂuoridemembrane using a semi-dry transfer system
(Bio-Rad). The membrane carrying the transferred proteins was in-
cubated at 4 °C overnight with the primary antibody at 1:200 dilution
in PBST buffer containing 0.1% Tween 20 and 5% nonfat dry milk.
Immunodetection was accomplished using horseradish peroxidase-
conjugated secondary antibody. Antibody binding was detected by the
ECL system, followed by exposure to an X-ray ﬁlm [12].
2.6. Membrane potential measurement of VSMCs in LIMA segments using
sharp microelectrode
Sharpmicroelectrodemethodsweremore appropriate for recording
cells in blood vessels [22]. The distal 10mmof LIMAswas obtained from
discarded tissues at coronary artery bypass grafting surgery, immedi-
ately placed in iced physiological saline. Segments of LIMAs were dis-
sected into about 3 mm rings, and periadventitial fat was removed.
Endothelial layer was mechanically rubbed off. The arterial segments
were opened longitudinally and equilibrated for 60 min in Krebs solu-
tion oxygenated with a gas mixture of 95% O2 and 5% CO2. Membrane
potentials were measured using glass microelectrodes ﬁlled with
3 mol/L KCl (resistance: 60–100 MΩ) as described elsewhere [12,23].
The arterial segments were opened longitudinally and the electrodes
were inserted into the VSMCs from the lumen side. Successful im-
palement was indicated by an abrupt drop in voltage, followed by a
sharp return to baseline on exit. Hyperpolarization of VSMCs to 11,12-
EET, GSK1016790A or 4α-PDD was recorded. In some experiments,
human LIMA segments were mounted on a wire myograph and sharp
microelectrodes were impaled from the adventitial side. In theseFig. 1. Co-immunoprecipitation of TRPV4, TRPC1 and KCa1.1(α) in the lysates of human LIMA
KCa1.1(α). The data are representative of 3 to 4 experiments. The pulling antibody and the b
using the preimmune IgG. IP, immunoprecipitation; Blot, immunoblot.experiments, the artery segments were pre-constricted with pheny-
lephrine, followed by 300 nmol/L 11,12-EET. If needed, the arteries
were pre-incubated at room temperature for 1 h with T1E3
(1:100) or pre-immune IgG (1:100), or at 37 °C for 30 min with
iberiotoxin (50 nmol/L), HC-067047 (10 μmol/L) or 14,15-EEZE
(10 μmol/L). Electrical signals were monitored continuously by an
EPC9 ampliﬁer (HEKA) with Pulse software. The currents were sam-
pled at 5 kHz and ﬁltered at 1 kHz. Data were analyzed with PulseFit
(HEKA). We determined the effect of 14,15-EEZE, HC-067047, T1E3,
or iberiotoxin pretreatment on basal resting membrane potentials
of the smooth muscle cells in phenylephrine-preconstricted LIMA
segments. The results showed that these treatments (30 min pre-
treatment with iberiotoxin or 14,15-EEZE or HC-067047; or 1 h
treatment with T1E3) had no signiﬁcant effect on the basal resting
membrane potentials.
2.7. Arterial tension measurement
We followed the method used by others, as described elsewhere
[17]. The LIMAs were removed of adhering connective tissues and cut
into 3-mm ring segments. If needed, the endothelium layer was denud-
ed by gently passing a knotted suture through the lumen. The successful
removal of the endothelial cell layer was veriﬁed by the lack of any re-
laxant response to acetylcholine (1 μmol/L). LIMA segmentswere equil-
ibrated for 45min in 10mL Krebs–Henseleit solution oxygenatedwith a
gasmixture of 95% O2 and 5% CO2 at 37 °C before experiments. The sam-
ples were excluded if they were not received in iced salinewithin 1 h of
harvest. Each ringwas suspended between two stainlesswire hooks in a
10 mL organ chamber ﬁlled with Krebs solution that contained in
mmol/L: 118 NaCl, 4.7 KCl, 25 NaHCO3, 2.5 CaCl2, 1 MgCl2, 1.2 KH2PO4,
and 11 D-glucose. The upper wire was connected to a force–disp-
lacement transducer (Grass Instruments, RI, USA) and the lower one
ﬁxed to the bottom of the organ bath. Rings were placed under anVSMCs. A and B, TRPC1 with KCa1.1(α). C and D, TRPC1 with TRPV4. E and F, TRPV4 with
lotting antibody were indicated (+). Control immunoprecipitation (−) was performed
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equilibrate for 90 min. The optimal tension was equivalent to that
generated at 0.9 times the diameter of the vessels at 100 mm Hg
[24].
The vessels were preconstricted with phenylephrine to the con-
traction force of ~1.4 g for each 3 mm artery segment. Cumulative
concentration of 11,12-EET or 5 μmol/L 4α-PDD was then added to
evoke relaxations. In experiments examining the role of TRPV4, KCa1.1
and TRPC1, the vascular segments were ﬁrst exposed to iberiotoxin
(50 nmol/L, 30 min), T1E3 (1:50, 1 h), or HC-067047 (10 μmol/L,
30 min), before contracting them with phenylephrine. The concentra-
tion of phenylephrine varied (3–10 μmol/L) in order to achieve a
similar degree of contraction (1.4 g/3 mm segment) for different
pretreatments. 11,12-EET or 4α-PDD was then applied. The effect
of preimmune IgG (1:50, 1 h) and 14,15-EEZE (10 μmol/L, 30 min)
was also tested.
2.8. Statistics
For comparison of multiple groups, one-way ANOVA with the
Newman–Keuls post hoc test was used. For comparison of two
groups, Student's t-test was used for statistical comparison. For com-
parison of two or more curves, two-way ANOVA followed by the
Bonferroni post hoc test was used. P b 0.05 was considered a signiﬁ-
cant difference.Fig. 2. Sharp microelectrodemeasurement of VSMCmembrane potentials in endothelium-denu
potential changes in response to 300 nmol/L 11,12-EET. D and E, summary of data showing them
nmol/L GSK1016790A or 5 μmol/L 4α-PDD (E). Values aremeans± SE (n=5 to 8). GSK, GSK10
control (without inhibitors); ##, P b 0.01 compared to preimmune IgG. $, P b 0.05 compared t3. Results
3.1. Physical interaction between TRPV4, TRPC1 and KCa1.1(α) in VSMCs of
human LIMAs
Co-immunoprecipitation was used to determine the physical inter-
action of KCa1.1(α), TRPC1 and TRPV4.We found that an anti-TRPC1 an-
tibody could pull down KCa1.1(α) (Fig. 1A) and TRPV4 (Fig. 1C) in cell
lysates freshly prepared from the primary cultured VSMCs derived
from human LIMAs. Furthermore, an anti-KCa1.1(α) antibody or an
anti-TRPV4 antibody could reciprocally pull down TRPC1 (Fig. 1B and
D). Moreover, the anti-TRPV4 antibody could pull down anti-
KCa1.1(α) (Fig. 1E), and the anti-KCa1.1(α) could reciprocally pull
down TRPV4 (Fig. 1F). For controls, the IgG puriﬁed from preimmune
serum failed to pull down TRPV4 or TRPC1 or anti-KCa1.1(α) (left lane
in Fig. 1A–F). All three antibodies used for co-immunoprecipitation
were previously shown by us and others to be highly speciﬁc to their re-
spective targets [12,19,25,26].
3.2. Role of TRPV4–TRPC1–KCa1.1 complex in 11,12-EET-, GSK1016790A-
and 4α-PDD-induced vascular smooth muscle cell hyperpolarization in
human LIMAs
We next directly measured the membrane potentials of VSMCs in
the endothelium-denuded human LIMA segments using sharpded human LIMA segments. A through C, representative traces illustrating themembrane
aximal changes ofmembrane potentials in response to 300 nmol/L 11,12-EET (D) and 100
16790A; IbTX, iberiotoxin; siTRPV4, TRPV4-siRNA;HC, HC-067047. *, P b 0.05 compared to
o scrambled siRNA.
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into longitudinally opened human LIMA segments [12,23]. Application
of 11,12-EET (300 nmol/L) or GSK1016790A (a TRPV4 speciﬁc agonist,
100 nmol/L) or 4α-PDD (a TRPV4 agonist, 5 μmol/L) each induced
smooth muscle hyperpolarization in human LIMA segments (Fig. 2).
The hyperpolarization was inhibited by a TRPV antagonist HC-067047
(10 μmol/L), a TRPV4 (human)-speciﬁc siRNA, a highly selective
KCa1.1(α) inhibitor iberiotoxin (50 nmol/L), a TRPC1-speciﬁc blocking
antibody T1E3 (1:100, 1 h pre-incubation) and T1E3 + HC-067047
(Fig. 2) [12,21]. In addition, if we increased IbTX concentration from
50nMto 500 nM, 11,12-EET-induced hyperpolarizationwas completely
abolished (Supplementary Fig. 1). These data suggest the involvement
of TRPV4, TRPC1 and KCa1.1 in the hyperpolarizing responses to 11,12-
EET and 4α-PDD. The action of 11,12-EET was also inhibited by 14,15-
EEZE (10 μmol/L) (Fig. 2A and D), which is a selective EET antagonist.
For control experiments, the effectiveness of TRPV4-siRNA was de-
monstrated in the western blots, in which TRPV4-siRNA was found to
reduce the TRPV4 protein expression by ~60% (Supplementary Fig. 2).Fig. 3.Effects of T1E3,HC-067047, iberiotoxin, TRPV4-siRNA and14,15-EEZEon11,12-EET- and
traces of dose-dependent vascular relaxation to 11,12-EET. D through H, summary of data show
T1E3 onvascular relaxation to 11,12-EET in endothelium-intact LIMA segments (D and E) anden
P b 0.05 compared to control (without inhibitors in D and F) or preimmune IgG (in E and G) o
dothelium-denuded, precontractedwith phenylephrine, followed by 5 μmol/L 4α-PDD for relax
compared to control (without inhibitors); #, P b 0.01 compared to preimmune. $$, P b 0.05 coFurthermore, TRPV4-siRNA had no effect on the expression of KCa1.1(α)
or TRPC1 (Supplementary Fig. 2).
Control experiments were also performed using microelectrode im-
palement from the adventitial side in intact arterial segments that were
pre-constricted with phenylephrine. The results were similar to those
obtained using microelectrode impalement from the lumen side in
longitudinally opened human LIMA segments (Supplementary Fig. 3).
In another control, the smooth muscle hyperpolarization of human
LIMAs to cromakalim (a KATP channel agonist, 1 μmol/L) was not affect-
ed by iberiotoxin, HC-067047 or T1E3 (Supplementary Fig. 4).
3.3. Role of TRPV4–TRPC1–KCa1.1(α) complex in 11,12-EET- and 4α-PDD-
induced vascular relaxation in human LIMAs
Human LIMA segments were preconstricted with varying concen-
trations of phenylephrine (3–10 μM) to induce similar degrees of con-
traction (~1.4 g/3 mm segment). Subsequent application of 11,12-EET
induced vascular relaxation dose-dependently in the arteries that4α-PDD-inducedvascular relaxation inhuman LIMA segments. A throughC, representative
ing the effects of HC-067047, iberiotoxin (IbTX), 14,15-EEZE, TRPV4-siRNA (siTRPV4) and
dothelium-denudedhumanLIMA segments (F–H). Values aremeans±SE (n=4 to10). *,
r scrambled siRNA (in H). I, the data summary is shown. Human LIMA segments were en-
ation. IbTX, iberiotoxin; siTRPV4, TRPV4-siRNA. Values aremeans± SE (n=4). **, P b 0.05
mpared to scrambled siRNA.
Fig. 4. Requirement of TRPC1 for TRPV4 and KCa1.1 interaction. A–D, co-immunoprecipitation of TRPV4 and KCa1.1(α) in the lysates of HEK293 cells. A and B, HEK293 cells that over-
expressed with TRPV4, TRPC1 and KCa1.1. C and D, HEK293 cells that over-expressed with TRPV4 and KCa1.1 but without TRPC1. The right lanes in C and D were immunoblots using
cell lysates without immunoprecipitation. The pulling antibody and the blotting antibody were indicated (+). Control immunoprecipitation (−) was performed using the preimmune
IgG. IP, immunoprecipitation; Blot, immunoblot. n = 3 to 4 experiments. E–F, the maximal hyperpolarization in response to 300 nmol/L 11,12-EET (E) and 5 μmol/L 4α-PDD (F) in
HEK293 cells that were transfected with indicated constructs. C1 stands for TRPC1. V4 stands for TRPV4. Values are means ± SE (n = 5 to 9). **P b 0.01 compared to the controls
(non-transfected), ##P b 0.01 compared to C1 + V4+ KCa1.1.
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ilarly, 4α-PDD also induced vascular relaxation (Fig. 3). The relaxations
to 11,12-EET and 4α-PDD were inhibited by HC-067047 (10 μmol/L),
TRPV4-siRNA, iberiotoxin (50 nmol/L) and T1E3 (1:50) (Fig. 3). 14,15-
EEZE (10 μmol/L) inhibited the relaxation to 11,12-EET (Fig. 3).
3.4. Role of TRPV4–TRPC1–KCa1.1(α) complex in 11,12-EET-, GSK1016790A-
and 4α-PDD-induced hyperpolarization in HEK293 overexpression system
HEK293 overexpression system was then used to explore the
detailed mechanisms of interaction between TRPV4, TRPC1 and
KCa1.1(α). Previously, we showed that TRPC1 co-immunoprecipitatedFig. 5.Membrane potential changes in HEK293 cells that over-expressed with TRPV4, TRPC1 a
nmol/L 11,12-EET (A), 5 μmol/L 4a-PDD (B) and 100 nmol/L GSK1016790A (C). D–F, summary o
PDD (E) and 100 nmol/L GSK1016790A (F) under different conditions. C1mut-pore, TRPC1 were
P b 0.01 compared to the controls (non-transfected); ##, P b 0.01 compared to the transfectedwith KCa1.1(α) and with TRPV4 [12,19], when they were co-expressed
in HEK293 cells. Here, we found that TRPV4 and KCa1.1(α) failed to
pull down each other when they were co-expressed (Fig. 4C and D).
However, when a third gene TRPC1 was also over-expressed, TRPV4
and KCa1.1(α) could pull down each other (Fig. 4A and B).
In the functional study, 11,12-EET, 4α-PDD and GSK1016790A could
induce membrane hyperpolarization in HEK293 cells that were over-
expressed with all three constructs, i.e. TRPV4, TRPC1 and KCa1.1(α)
(Fig. 4E and F, Fig. 5C and F), but they had little effect in cells that
were only co-transfected with KCa1.1(α) and TRPV4 without TRPC1 or
KCa1.1(α) and TRPC1 without TRPV4 (Fig. 4E and F). Again, the hyper-
polarization to 11,12-EET, 4α-PDD and GSK1016790A was inhibitednd KCa1.1. A and B, representative traces illustrating the hyperpolarizing responses to 300
f data showing the maximal hyperpolarization to 300 nmol/L 11,12-EET (D), 5 μmol/L 4a-
replaced by a TRPC1 pore-dead mutant C1mut-pore. Values are means ± SE (n= 5 to 9). **,
cells without inhibitors; $$, P b 0.01 compared to preimmune IgG.
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(Fig. 5). The hyperpolarization to 11,12-EET was inhibited by 14,15-
EEZE (10 μmol/L) (Fig. 5). We also utilized a TRPC1 pore-dead mutant
TRPC1mut-pore, which carries the point mutations at the pore region of
TRPC1 [27]. Replacement of TRPC1 with TRPC1mut-pore also markedly
reduced the hyperpolarizing responses to 11,12-EET, 4α-PDD and
GSK1016790A (Fig. 5).
4. Discussion
The major novel ﬁndings of this study are as follows: (1) co-
immunoprecipitation experiments demonstrated that TRPV4, TRPC1
and KCa1.1 form a physical complex in human LIMA VSMCs and TRPV4–
TRPC1–KCa1.1 co-expressing HEK293 cells; (2) electrophysiological re-
cordings showed that 11,12-EET and 4α-PDD act through the TRPV4–
TRPC1–KCa1.1 complex to induce membrane hyperpolarization; and
(3) arterial tension measurement showed that 11,12-EET acts through
the TRPV4–TRPC1–KCa1.1 complex to induce vascular relaxation in
human LIMAs. Together, these data suggest that EETs act through the
TRPV4–TRPC1–KCa1.1 complex to induce smoothmuscle cell hyperpolar-
ization and vascular relaxation.
For coronary artery bypass surgery, human LIMA grafts have superi-
or long-term patency rates and improved survival as compared to sa-
phenous vein grafts [16]. The beneﬁt of LIMAs over saphenous veins
onmortality has been consistently observed irrespective of age and gen-
der [28]. This could be attributed to several reasons: 1) LIMA grafts rare-
ly develop atherosclerosis [16]; and 2) LIMAs release more protective
vasodilators including nitric oxide and EDHFs. Reports showed that
11,12-EET, as a major EDHF in human LIMAs, activates KCa1.1 current
to induce smooth muscle cell hyperpolarization and vascular relaxation
[17]. However, thedetailedmolecularmechanisms of howEET could ac-
tivate KCa1.1 to induce vascular relaxation in human LIMAs remain ob-
scure. In the present study, we found that the 11,12-EET-induced
smooth muscle cell hyperpolarization and relaxation in human LIMAs
were inhibited by iberiotoxin, conﬁrming the involvement of KCa1.1.
Furthermore, HC-067047, TRPV4-siRNA, and T1E3 markedly inhibited
the EET-induced membrane hyperpolarization and/or relaxation in
human LIMAs, suggesting an important role of TRPV4 and TRPC1 in
the processes.
Interestingly, co-immunoprecipitation experiments demonstrated
that TRPV4, TRPC1 and KCa1.1 physically associated with each other to
form a complex in human LIMA smooth muscle cells. Such a complex
should allow efﬁcient signal transduction delivered to KCa1.1, the activ-
ity ofwhich is expected to induce smoothmuscle hyperpolarization and
vascular relaxation.
As for signaling pathway, presumably 11,12-EET is expected to ﬁrst
act on TRPV4, because TRPV4 contains an EET binding site [3–6]. This
idea was supported by a series of experiments in which we found that
the actions of 11,12-EET resembled those of 4α-PDD, which is a selec-
tive agonist of TRPV4. Similar to 11,12-EET, 4α-PDD could also induce
smooth muscle hyperpolarization and vascular relaxation in human
LIMAs. Furthermore, the actions of 4α-PDD were inhibited by
iberiotoxin and T1E3, suggesting that TRPC1 andKCa1.1 are downstream
of TRPV4. Alternatively, TRPV4may heteromerize with TRPC1 to form a
heteromeric channel, the activity of which may then activate KCa1.1.
Such heteromeric TRPV4–TRPC1 channels are previously known to be
present in vascular endothelial cells [19]. To further exclude the possi-
bility that TRPC1 and TRPV4may activate KCa1.1 via two independently
pathways, we examined the combined effect of HC-067047 + T1E3 on
11,12-EET-induced smooth muscle hyperpolarization. The results
showed that the combined application of HC-067047+T1E3hadno ad-
ditional effect compared to that of HC-067047, conﬁrming that TRPC1
and TRPV4 share a single signaling pathway.
HEK293 cells are a commonly used system for gene overexpression.
The system offers the advantage of low expression level of endogenous
proteins, thus the function of exogenously expressed proteins can bestudied with less ambiguity. In membrane potential recording experi-
ments, 11,12-EET, GSK1016790A and 4α-PDD were able to induce
membrane hyperpolarization in HEK293 cells that were overexpressed
with TRPV4, TRPC1 and KCa1.1. Co-immunoprecipitation experiments
demonstrated that TRPV4, TRPC1 and KCa1.1 also form a physical com-
plex in HEK293 overexpression system (Fig. 4 and Ref. [12,19]). Inter-
estingly, TRPV4 and KCa1.1(α) failed to pull down each other in the
absence of TRPC1, indicating that TRPV4 and KCa1.1(α) are not capable
of forming a physical complex on their own. The physical association be-
tween TRPV4 and KCa1.1(α) only occurred in the presence of TRPC1
(Fig. 4). In agreement, 4α-PDD and 11,12-EET failed to induce mem-
brane hyperpolarization in HEK293 cells that over-expressed with
TRPV4 and KCa1.1(α). In contrast, a marked hyperpolarization occurred
when the HEK293 cells were also transfected with a third gene, TRPC1.
These results suggest that TRPC1 serves as a linker through which
TRPV4 and KCa1.1(α) can interact physically and functionally, thus en-
abling EET- and 4α-PDD-induced membrane hyperpolarization.
Our present model of EET action on TRPV4–TRPC1–KCa1.1 complex
differed from an early model by Earley et al. [4] in two aspects: 1) in
our model, an additional component TRPC1 is added. TRPC1 appears
to act as a linker through which TRPV4 and KCa1.1(α) can interact and
2) in our model, TRPV4, TRPC1 and KCa1.1(α) are physically associated,
whereas no physical interaction is suggested in Earley's model.
5. Conclusions
Wedemonstrated that TRPV4, TRPC1 andKCa1.1 physically associate
with each other to form a signaling complex in human LIMA vascular
smooth muscle cells. 11,12-EET acts on the TRPV4–TRPC1–KCa1.1 com-
plex to induce VSMC hyperpolarization and vascular relaxation in
human LIMAs. This ﬁnding is of clinical importance, because human
LIMAs are important donor tissue in coronary bypass surgery, and pro-
vides the physiological relevance of endothelium-derived hyperpolariz-
ing factors in LIMAs.
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